tiprankstipranks
Advertisement
Advertisement
Septerna initiated with a Buy at Guggenheim
PremiumThe FlySepterna initiated with a Buy at Guggenheim
1M ago
Septerna to present preclinical characterization of SEP-479
Premium
The Fly
Septerna to present preclinical characterization of SEP-479
2M ago
Septerna price target raised to $53 from $47 at Raymond James
Premium
The Fly
Septerna price target raised to $53 from $47 at Raymond James
2M ago
3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts
PremiumMarket News3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts
3M ago
Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target
Premium
Ratings
Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target
3M ago
Septerna Begins Phase 1 Trial of Oral SEP-479
Premium
Company Announcements
Septerna Begins Phase 1 Trial of Oral SEP-479
3M ago
Septerna files automatic mixed securities shelf
PremiumThe FlySepterna files automatic mixed securities shelf
5M ago
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
Premium
Ratings
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
5M ago
Septerna reports Q4 EPS (24c), consensus (22c)
Premium
The Fly
Septerna reports Q4 EPS (24c), consensus (22c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100